LlaMABody-Camelid Antibodies

Camelid antibodies and VHH antibodies are now offered through R&D Systems.

Isotype Control antibody

Camelid antibodies have started to be used in many forms of research including studying of protein structure, high resolution imaging applications, drug delivery, as well as detection and neutralization of viruses. Due to the smaller size, these antibodies can detect epitopes that are more difficult to reach than the conventional antibody.

R&D Systems is pleased to offer multiple forms of camelid antibodies in our LlaMABody product line. We offer:

  • Native llama heavy chain IgG antibodies
  • VHH antibody domains
  • VHH domains on a human IgG scaffold

We are pleased to feature our first SARS-CoV-1/2 Spike RBD Llamabody™ Antibody  that is based on the published SARS VHH-72 clone. The SARS-CoV-1/2 Spike RBD Llamabody™ Antibody is a recombinantly expressed antibody that has the VHH domain of the SARS VHH-72 clone and is attached to a human IgG scaffold. With the small size of the VHH domain and the ability to reach more difficult epitopes, this product has the ability to block both SARS-CoV-1 and SARS-CoV-2.

View Our Product

 

Contents:

 

What are Camelid Antibodies?

Camelid antibodies are antibodies from the Camelidae family of mammals that include llamas, camels, and alpacas. These animals produce 2 main types of antibodies. One type of antibody camelids produce is the conventional antibody that is made up of 2 heavy chains and 2 light chains. They also produce another type of antibody that is made up of only 2 heavy chains. This is known as heavy chain IgG (hcIgG). While these antibodies do not contain the CH1 region, they retain an antigen binding domain called the VHH region. VHH antibodies, also known as single domain antibodies or Nanobodies®, contain only the VHH region from the camelid antibody.

Camelid antibodies are made up of only 2 heavy chains and contain a binding domain call the VHH region.

 

Advantages of Camelid Antibodies

VHH antibodies can provide many benefits over traditional IgG antibodies. VHH antibodies are about 15kDa in size compared to the 150kDa size of an IgG antibody. Due to their smaller size they are able to detect certain epitopes that may not have been accessible with a traditional antibody due to steric hindrance. They are also able to penetrate tissue and enter cells easier allowing for more specific IHC staining and intracellular flow cytometry staining. The VHH antibodies are also more stable and can withstand a larger pH and temperature range.

 

Custom Services

At R&D Systems, we have optimized a platform for custom recombinant antibody development and are able to provide additional products that may not be found in our catalog. By using our extensive recombinant antibody knowledge, we are able to provide custom LlaMABody products that include VHH antibodies (single domain antibodies) and bivalent VHH antibodies.

View Our Antibody Custom Services

 

Nanobody and nanobodies are registered trademarks of Ablynx N.V.